LIMN Liminatus Pharma, Inc.

Nasdaq liminatuspharma.com


$ 1.52 $ 0.12 (8.57 %)    

Wednesday, 29-Oct-2025 12:18:01 EDT
QQQ $ 634.59 $ -0.94 (-0.15 %)
DIA $ 479.83 $ 1.22 (0.25 %)
SPY $ 688.13 $ -0.60 (-0.09 %)
TLT $ 91.74 $ -0.14 (-0.15 %)
GLD $ 367.87 $ -1.78 (-0.48 %)
$ 1.42
$ 1.43
$ 1.51 x 125
$ 1.52 x 400
$ 1.32 - $ 1.52
$ 1.11 - $ 33.66
1,386,038
na
33.09M
$ -1.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-04-2025 06-30-2025 10-Q
2 05-31-2025 03-31-2025 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), La Palma, CA, a clinical-stage immuno-oncology company developing next-generation CD47-bl...

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. has entered into a Memorandum of Understanding (MOU) to form a research and development consortium with ...

 us-stocks-likely-to-open-higher-sp-500-sees-average-gain-of-61-in-2nd-half-expert-says

U.S. futures rose on Wednesday after a mixed close on Tuesday. Futures of major benchmark indices were trading slightly higher.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION